Pharmacists in Dubuque, Iowa


109 Pharmacists found in Dubuque
male pharmacist

Ronald L Hunt, RPH


Pharmacist
2260 John F Kennedy Rd, Dubuque, IA 52002
563-582-1659     563-582-1863

female pharmacist

Dr. Sarah Ann Vandermillen, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
157 Locust St, Dubuque, IA 52001
563-588-8702    

female pharmacist

Dr. Shanrael Stoner, PHARM D, MPH


Pharmacist
2255 John F Kennedy Rd Ste 16, Dubuque, IA 52002
563-588-8703    



female pharmacist

Mrs. Sheri Marie Buser, RPH


Pharmacist
535 Hill St, Dubuque, IA 52001
563-588-4033     563-588-4044

female pharmacist

Stacy Kaalberg, PHARMD


Pharmacist
3500 Dodge St, Dubuque, IA 52003
563-583-3858     563-583-2209

male pharmacist

Dr. Stephen Schwab, PHARM D


Pharmacist
345 E 20th St, Dubuque, IA 52001
563-690-1836     563-690-1842

male pharmacist

Steven Anthony Link, RPH


Pharmacist
400 S Locust, Dubuque, IA 52003
563-582-1143     563-557-7453

female pharmacist

Susan E Purcell, RPH


Pharmacist
535 Hill St, Dubuque, IA 52001
563-588-4033     563-588-4044

female pharmacist

Susan A Neuser, RPH


Pharmacist
74 25 Chavenelle Rd, Dubuque, IA 52002
563-588-8709    

female pharmacist

Talia Nicole Santos


Pharmacist
7425 Chavenelle Rd Ste 300, Dubuque, IA 52002
563-588-8709    

female pharmacist

Dr. Terese Nickol Kruse, PHARMD.


Pharmacist
1920 Elm St, Dubuque, IA 52001
563-589-8970    

male pharmacist

Mr. Todd Shields, RPH


Pharmacist
3500 Dodge St, Hy-vee Pharmacy, Dubuque, IA 52003
563-583-3858    

female pharmacist

Traci Schmitt, RPH


Pharmacist
2395 Nw Arterial, Dubuque, IA 52002
563-582-3436     563-583-3282


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.